• Facilities
    • Cork, Ireland
    • Cramlington, UK
    • Deeside, UK
    • Newcastle Biosphere, UK
    • North Carolina, US
    • Wisconsin, US
  • Sustainability
    • Environmental sustainability
  • Molecule Lifecycle
    • Discovery
    • Preclinical
    • Phase One
    • Phase Two
    • Phase Three
    • Launch
  • About Us
    • Our Heritage
    • Vision and Values
    • HSE
    • Quality and Regulatory
    • Technology and Innovation Programme
    • PDMO
    • Executive Team
    • Community
  • Careers Hub
    • Our Vacancies
    • Life at Sterling
    • STEM
    • Early Career Paths at Sterling
    • Professional Career Paths at Sterling
    • Meet our People
    • Our Locations
  • News and Events
    • News
    • Events
  • Contact
Sterling Pharma Solutions Logo
Sterling Pharma Solutions Logo
✕
  • Dedicated Scientists
    • Full Time Equivalent (FTE)
    • Extended Bench™
  • Chemistry Services
    • Drug Discovery
    • Early Scale Up
    • Analytical Services
    • Radiolabelling
  • Small Molecules
    • Small Molecule Services
      • API Development
      • API Manufacturing
      • CMC Services
      • Solid State Chemistry
      • Milling/Micronisation
    • Small Molecule Technologies
      • Hazard Evaluation
      • Chiral Chemistry
      • Hazardous Chemistry
      • Diazomethane
      • Continuous | Flow
      • Biocatalysis
      • High Potency APIs
      • Controlled Substances
  • Peptides
  • ADCs
    • ADC Development
    • ADC Analytical Services
    • Mass Spectrometry
    • ADC Clinical Manufacturing
    • Linker Payloads
  • Knowledge Hub
  • Home
  • Dedicated Scientists
    • Full Time Equivalent (FTE)
    • Extended Bench™
  • Chemistry Services
    • Drug Discovery
    • Early Scale Up
    • Analytical Services
    • Radiolabelling
  • Small Molecules
    • Small Molecule Services
      • API Development
      • API Manufacturing
      • CMC Services
      • Solid State Chemistry
      • Milling/Micronisation
    • Small Molecule Technologies
      • Hazard Evaluation
      • Chiral Chemistry
      • Hazardous Chemistry
      • Diazomethane
      • Continuous | Flow
      • Biocatalysis
      • High Potency APIs
      • Controlled Substances
  • Peptides
  • ADCs
    • ADC Development
    • ADC Analytical Services
    • Mass Spectrometry
    • ADC Clinical Manufacturing
    • Linker Payloads
  • Molecule Lifecycle
  • Knowledge Hub
  • About Us
    • Our Heritage
    • HSE
    • Quality and Regulatory
    • Technology and Innovation Programme
    • PDMO
    • Executive Team
    • Community
  • Facilities
  • Sustainability
  • Careers Hub
    • Our Vacancies
    • Life at Sterling
    • STEM
    • Early Career Paths at Sterling
    • Professional Career Paths at Sterling
    • Vision and Values
    • Meet our People
    • Our Locations
  • News and Events
  • Contact
Home -

Sign up to our newsletter

Direct to your inbox, every other month.

This field is for validation purposes and should be left unchanged.
Name(Required)
This field is hidden when viewing the form
Please click here for our privacy policy
Sterling Pharma Solutions Footer LogoService. Passion. Science.
linkedin iconfacebook iconyoutube icon
Enquire now
  • Privacy Policy
  • Cookie Policy
  • Manage Cookies
  • Website Terms and Conditions
  • Gender Pay Gap
  • Modern Slavery Policy

PDMO® is registered in the U.S. Patent and Trademark Office.

PDMO® is a registered trademark of Sterling Pharma Solutions Limited (EUIPO and UKIPO). All rights reserved.

Sterling Pharma Solutions Limited. Registration number: 05712796. Registered office address: Dudley Lane, Dudley, Cramlington, NE23 7QG, United Kingdom. Registered in England.
VAT number: GB320549229